Augusta University
Two immunotherapies are being given together for the first time to help more patients wage a stronger war on a wide range of solid tumors.
Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report. Studies of two T cell types that are equally activated by alpha-fetoprotein, a well-established antigen made by liver cancer...
